Mineralys Therapeutics Inc
(NAS:MLYS)
$
25.65
-0.10 (-0.39%)
Market Cap: 2.27 Bil
Enterprise Value: 1.61 Bil
PE Ratio: 0
PB Ratio: 4.11
GF Score: 33/100 Mineralys Therapeutics Inc (MLYS) Transcripts
- 1